BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Viterbo D, Gausman V, Gonda T. Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy. World J Gastrointest Endosc 2016; 8(3): 128-142 [PMID: 26862363 DOI: 10.4253/wjge.v8.i3.128]
URL: https://www.wjgnet.com/1948-5190/full/v8/i3/128.htm
Number Citing Articles
1
Alexander Ney, Andres Garcia-Sampedro, George Goodchild, Pilar Acedo, Giuseppe Fusai, Stephen P. Pereira. Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic ConundrumFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699401
2
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky, A. V. Chzhao. Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review)Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2019; 23(4): 108 doi: 10.16931/1995-5464.20184108-117
3
Daniele Dondossola, Michele Ghidini, Francesco Grossi, Giorgio Rossi, Diego Foschi. Practical review for diagnosis and clinical management of perihilar cholangiocarcinomaWorld Journal of Gastroenterology 2020; 26(25): 3542-3561 doi: 10.3748/wjg.v26.i25.3542
4
Zeeshan Sattar, Saeed Ali, Ishtiaq Hussain, Farhan Sattar, Sana Hussain, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer2019; : 51 doi: 10.1016/B978-0-12-819457-7.00002-5
5
Didi Liu, Jun Li, Yue Xue, Ting Zhao, Zhehui Jin, Wei Dan, Zexuan Chen, Liangshuo Hu, Shisheng Sun. Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinomaInternational Journal of Biological Macromolecules 2024; 280: 135563 doi: 10.1016/j.ijbiomac.2024.135563
6
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosisSurgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
7
Jérôme Raffenne, Jérôme Cros. La caractérisation moléculaire définit plusieurs sous-types d’adénocarcinome canalaire du pancréasBulletin du Cancer 2018; 105(1): 55 doi: 10.1016/j.bulcan.2017.11.010
8
Hongyu Xie, Yan Hou, Jinlong Cheng, Margarita S. Openkova, Bairong Xia, Wenjie Wang, Ang Li, Kai Yang, Junnan Li, Huan Xu, Chunyan Yang, Libing Ma, Zhenzi Li, Xin Fan, Kang Li, Ge Lou. Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancerOncotarget 2017; 8(19): 32134 doi: 10.18632/oncotarget.16739
9
George Georgiadis, Charalampos Belantis, Charalampos Mamoulakis, John Tsiaoussis, Wallace A. Hayes, Aristidis M. Tsatsakis. Biomarkers in Toxicology2019; : 855 doi: 10.1016/B978-0-12-814655-2.00047-5
10
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, Claudia Cinque, Stefania Farace, Renato Patrone, Vincenza Granata, Andrea Zovi, Guglielmo Nasti, Alessandro Ottaiano. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatmentsMolecular and Cellular Probes 2024; 73: 101951 doi: 10.1016/j.mcp.2024.101951
11
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsOncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
12
Steven Alexander Mann, Romil Saxena. Predictive Biomarkers in Oncology2019; : 437 doi: 10.1007/978-3-319-95228-4_40
13
Ying Yang, Shirong Yan, Hui Tian, Yixi Bao. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19–9 as a biomarker for diagnosis of pancreatic cancerMedicine 2018; 97(9): e9994 doi: 10.1097/MD.0000000000009994
14
F. Rassam, E. Roos, K. P. van Lienden, J. E. van Hooft, H. J. Klümpen, G. van Tienhoven, R. J. Bennink, M. R. Engelbrecht, A. Schoorlemmer, U. H. W. Beuers, J. Verheij, M. G. Besselink, O. R. Busch, T. M. van Gulik. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experienceLangenbeck's Archives of Surgery 2018; 403(3): 289 doi: 10.1007/s00423-018-1649-2
15
Alexander M. Sarkisian, Reem Z. Sharaiha. ERCP2019; : 385 doi: 10.1016/B978-0-323-48109-0.00040-7
16
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binnebösel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann, Tom Luedde. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17175-7
17
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinomaCritical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015